Skip to main content
Journal cover image

Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.

Publication ,  Journal Article
Allocca, CM; Snapes, E; Albert, M; Bledsoe, MJ; Castelhano, MG; De Wilde, M; Furuta, K; Kozlakidis, Z; Martin, D; Martins, A; McCall, SJ; Schacter, B
Published in: Biopreserv Biobank
December 2020

The COVID-19 era has brought about a number of novel challenges for the global biobanking community. An array of diverse tools (e.g., standards, best practices, and plans) exists to support quality and fitness-for-purpose in biobank operations. The International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force has set out to identify needs and gaps in these tools and make recommendations for the next generation of available tools, having closely examined the COVID-19-related challenges. While conducting this work to examine the relationships between tools and biobank adaptability, a subgroup of the task force conducted a parallel effort to develop and describe individual COVID-19 era case studies based on a number of operating biobanks. Each case study presents a different combination of implemented tools. Observations and lessons learned from these case studies are provided, and experiences with tool implementation are discussed. This information is supplemented by data relating to tool usefulness that was obtained through an ISBER survey discussed in a companion article. The knowledge gained from this study will be combined with other task force efforts to make recommendations to better position the biobanking community in their response to future emergencies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biopreserv Biobank

DOI

EISSN

1947-5543

Publication Date

December 2020

Volume

18

Issue

6

Start / End Page

547 / 560

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pandemics
  • Humans
  • COVID-19
  • Biomedical Research
  • Biological Specimen Banks
  • 3102 Bioinformatics and computational biology
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Allocca, C. M., Snapes, E., Albert, M., Bledsoe, M. J., Castelhano, M. G., De Wilde, M., … Schacter, B. (2020). Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies. Biopreserv Biobank, 18(6), 547–560. https://doi.org/10.1089/bio.2020.0083
Allocca, Clare M., Emma Snapes, Monique Albert, Marianna J. Bledsoe, Marta G. Castelhano, Mieke De Wilde, Koh Furuta, et al. “Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.Biopreserv Biobank 18, no. 6 (December 2020): 547–60. https://doi.org/10.1089/bio.2020.0083.
Allocca CM, Snapes E, Albert M, Bledsoe MJ, Castelhano MG, De Wilde M, et al. Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies. Biopreserv Biobank. 2020 Dec;18(6):547–60.
Allocca, Clare M., et al. “Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.Biopreserv Biobank, vol. 18, no. 6, Dec. 2020, pp. 547–60. Pubmed, doi:10.1089/bio.2020.0083.
Allocca CM, Snapes E, Albert M, Bledsoe MJ, Castelhano MG, De Wilde M, Furuta K, Kozlakidis Z, Martin D, Martins A, McCall SJ, Schacter B. Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies. Biopreserv Biobank. 2020 Dec;18(6):547–560.
Journal cover image

Published In

Biopreserv Biobank

DOI

EISSN

1947-5543

Publication Date

December 2020

Volume

18

Issue

6

Start / End Page

547 / 560

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pandemics
  • Humans
  • COVID-19
  • Biomedical Research
  • Biological Specimen Banks
  • 3102 Bioinformatics and computational biology
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology